1. Home
  2. SUNS vs NTHI Comparison

SUNS vs NTHI Comparison

Compare SUNS & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunrise Realty Trust Inc.

SUNS

Sunrise Realty Trust Inc.

HOLD

Current Price

$7.50

Market Cap

108.7M

Sector

Real Estate

ML Signal

HOLD

Logo NeOnc Technologies Holdings Inc.

NTHI

NeOnc Technologies Holdings Inc.

HOLD

Current Price

$4.70

Market Cap

121.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUNS
NTHI
Founded
2023
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
108.7M
121.3M
IPO Year
2024
2023

Fundamental Metrics

Financial Performance
Metric
SUNS
NTHI
Price
$7.50
$4.70
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$8.75
$15.00
AVG Volume (30 Days)
78.9K
248.1K
Earning Date
05-14-2026
05-19-2026
Dividend Yield
16.17%
N/A
EPS Growth
N/A
N/A
EPS
0.54
N/A
Revenue
$21,571,434.00
$39,990.00
Revenue This Year
$70.81
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.96
N/A
Revenue Growth
102.96
N/A
52 Week Low
$7.34
$3.01
52 Week High
$11.78
$12.99

Technical Indicators

Market Signals
Indicator
SUNS
NTHI
Relative Strength Index (RSI) 42.95 56.29
Support Level $7.38 $4.18
Resistance Level $8.04 $5.79
Average True Range (ATR) 0.20 0.71
MACD 0.00 0.05
Stochastic Oscillator 36.21 56.32

Price Performance

Historical Comparison
SUNS
NTHI

About SUNS Sunrise Realty Trust Inc.

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS, and debt-like preferred equity securities across CRE asset classes and investment mix to include high-quality multi-family, condominiums, retail, office, hospitality, industrial, mixed-use, and specialty-use real estate. The company's portfolio is concentrated in the Southern U.S.

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

Share on Social Networks: